Study of Antibiotic Resistant Genes in Isolated from Burns and Wounds

Overview

Journal Arch Razi Inst

Specialties Allergy & Immunology
General Medicine
Veterinary Medicine

Date 2022 Jul 27

PMID 35891744

Authors

A Rashid Mahmood

N Mansour Hussein

Affiliations

Soon will be listed here.

Abstract

() is frequently associated with infections with high mortality rates. The intrinsically high resistance to many antibiotics and multidrug resistance in the hospital setting is considered to be among the reasons for high pathogenicity of . In this study, a total of 200 wound and burn swabs were collected from patients. The collected specimens were examined for through biochemical and antibacterial sensitivity tests performed in the Microbiology Laboratory in College of Medicine, University of Kirkuk, Kirkuk, Iraq. The polymerase chain reaction was then used to detect mexA, mexB, mexR, and oprD genes. In total, 31 isolates of were collected from 200 patients with wounds and burns. Most cases were isolated from 23 (74.19%) and 8 (25.80%) wound and burn swabs, respectively. Antibiotic sensitivity was tested on all isolates against 17 antimicrobial agents. The obtained results revealed a high resistance rate to gentamicin, trimethoprim, amikacin, and amoxicillin, and a low resistance rate was observed to ceftazidime, tobramycin, levofloxacin, cotrimoxazole, ciprofloxacin, and aztreonam. Regarding antibiotic resistance, mexB, mexR, and oprD genes were observed in three isolates, in which mexB and mexR were detected in two isolates, and only one isolate carried mexA gene.

Citing Articles

Conflict-associated wounds and burns infected with GLASS pathogens in the Eastern Mediterranean Region: A systematic review.

Wild A, Shortall C, Dewachi O, Naim C, Green A, Hussain S BMC Infect Dis. 2025; 25(1):187.

PMID: 39920648 PMC: 11806698. DOI: 10.1186/s12879-025-10569-3.

Understanding the pathophysiology of colonization as a guide for future treatment for chronic leg ulcers.

Matheus G, Chamoun M, Khosrotehrani K, Sivakumaran Y, Wells T Burns Trauma. 2025; 13():tkae083.

PMID: 39830194 PMC: 11741523. DOI: 10.1093/burnst/tkae083.

Molecular Properties of Virulence and Antibiotic Resistance of Causing Clinically Critical Infections.

Monroy-Perez E, Herrera-Gabriel J, Olvera-Navarro E, Ugalde-Tecillo L, Garcia-Cortes L, Moreno-Noguez M Pathogens. 2024; 13(10).

PMID: 39452738 PMC: 11510431. DOI: 10.3390/pathogens13100868.

Imidazoles and Quaternary Ammonium Compounds as Effective Therapies against (Multidrug-Resistant) Bacterial Wound Infections.

Van de Vliet L, Vackier T, Thevissen K, Decoster D, Steenackers H Antibiotics (Basel). 2024; 13(10).

PMID: 39452215 PMC: 11505196. DOI: 10.3390/antibiotics13100949.

Monooxygenases and Antibiotic Resistance: A Focus on Carbapenems.

Minerdi D, Loqui D, Sabbatini P Biology (Basel). 2023; 12(10).

PMID: 37887026 PMC: 10604202. DOI: 10.3390/biology12101316.

References

Tamber S, Maier E, Benz R, Hancock R . Characterization of OpdH, a Pseudomonas aeruginosa porin involved in the uptake of tricarboxylates. J Bacteriol. 2006; 189(3):929-39. PMC: 1797325. DOI: 10.1128/JB.01296-06. View

Rhomberg P, Fritsche T, Sader H, Jones R . Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Diagn Microbiol Infect Dis. 2006; 56(1):57-62. DOI: 10.1016/j.diagmicrobio.2005.12.009. View

Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K . Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet. 2003; 362(9399):1888-93. DOI: 10.1016/S0140-6736(03)14959-8. View

Banerjee S, Batabyal K, Joardar S, Isore D, Dey S, Samanta I . Detection and characterization of pathogenic from bovine subclinical mastitis in West Bengal, India. Vet World. 2017; 10(7):738-742. PMC: 5553139. DOI: 10.14202/vetworld.2017.738-742. View

Fernandez L, Hancock R . Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012; 25(4):661-81. PMC: 3485749. DOI: 10.1128/CMR.00043-12. View

Pryor K, Fahey 3rd T, Lien C, Goldstein P . Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA. 2004; 291(1):79-87. DOI: 10.1001/jama.291.1.79. View

Tian Z, Yi X, Cho A, OGara F, Wang Y . CpxR Activates MexAB-OprM Efflux Pump Expression and Enhances Antibiotic Resistance in Both Laboratory and Clinical nalB-Type Isolates of Pseudomonas aeruginosa. PLoS Pathog. 2016; 12(10):e1005932. PMC: 5063474. DOI: 10.1371/journal.ppat.1005932. View

Agnihotri N, Gupta V, Joshi R . Aerobic bacterial isolates from burn wound infections and their antibiograms--a five-year study. Burns. 2004; 30(3):241-3. DOI: 10.1016/j.burns.2003.11.010. View

Aghazadeh M, Hojabri Z, Mahdian R, Nahaei M, Rahmati M, Hojabri T . Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Infect Genet Evol. 2014; 24:187-92. DOI: 10.1016/j.meegid.2014.03.018. View

10.

Lambert P . Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med. 2002; 95 Suppl 41:22-6. PMC: 1308633. View

11.

Nouer S, Nucci M, de-Oliveira M, Pellegrino F, Moreira B . Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Antimicrob Agents Chemother. 2005; 49(9):3663-7. PMC: 1195411. DOI: 10.1128/AAC.49.9.3663-3667.2005. View

12.

Siriyong T, Srimanote P, Chusri S, Yingyongnarongkul B, Suaisom C, Tipmanee V . Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC Complement Altern Med. 2017; 17(1):405. PMC: 5557310. DOI: 10.1186/s12906-017-1913-y. View

13.

Sambrano H, Castillo J, Ramos C, de Mayorga B, Chen O, Duran O . Prevalence of antibiotic resistance and virulent factors in nosocomial clinical isolates of Pseudomonas aeruginosa from Panamá. Braz J Infect Dis. 2020; 25(1):101038. PMC: 9392144. DOI: 10.1016/j.bjid.2020.11.003. View

14.

Ekrami A, Kalantar E . Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res. 2008; 126(6):541-4. View

15.

Ullah W, Qasim M, Rahman H, Khan S, Rehman Z, Ali N . CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan. Microb Pathog. 2017; 105:240-244. DOI: 10.1016/j.micpath.2017.02.039. View

16.

Lescat M, Poirel L, Tinguely C, Nordmann P . A Resazurin Reduction-Based Assay for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii and Pseudomonas aeruginosa. J Clin Microbiol. 2018; 57(3). PMC: 6425163. DOI: 10.1128/JCM.01563-18. View

17.

Kishk R, Abdalla M, Hashish A, Nemr N, El Nahhas N, Alkahtani S . Efflux -Mediated Resistance in Isolated from Patients with Healthcare Associated Infections. Pathogens. 2020; 9(6). PMC: 7350317. DOI: 10.3390/pathogens9060471. View

18.

Strateva T, Ouzounova-Raykova V, Markova B, Todorova A, Marteva-Proevska Y, Mitov I . Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J Med Microbiol. 2007; 56(Pt 7):956-963. DOI: 10.1099/jmm.0.46986-0. View

19.

Zeng Z, Wang W, Huang M, Shi L, Wang Y, Shao H . Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China. Diagn Microbiol Infect Dis. 2013; 78(3):268-70. DOI: 10.1016/j.diagmicrobio.2013.11.014. View

20.

Rice L . Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol. 2010; 31 Suppl 1:S7-10. DOI: 10.1086/655995. View